ATC code B06 (original) (raw)

From Wikipedia, the free encyclopedia

Pharmaceutical drug classification

ATC code B06 Other hematological agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup B06 is part of the anatomical group B Blood and blood forming organs.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB06.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B06AA02 Fibrinolysin and desoxyribonuclease

B06AA03 Hyaluronidase

B06AA04 Chymotrypsin

B06AA07 Trypsin

B06AA10 Desoxyribonuclease

B06AA55 Streptokinase, combinations

B06AB01 Hemin

B06AC01 C1-inhibitor, plasma derived

B06AC02 Icatibant

B06AC03 Ecallantide

B06AC04 Conestat alfa

B06AC05 Lanadelumab

B06AC06 Berotralstat

B06AC07 Garadacimab

B06AC08 Sebetralstat

B06AX Other hematological agents

[edit]

B06AX01 Crizanlizumab

B06AX02 Betibeglogene autotemcel

B06AX03 Voxelotor

B06AX04 Mitapivat

B06AX05 Exagamglogene autotemcel

1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. ^ "ATC/DDD Index 2022: code B06". WHO Collaborating Centre for Drug Statistics Methodology.
5. ^ "ATCvet Index 2022: code QB06". WHO Collaborating Centre for Drug Statistics Methodology.